Clinical trial
PRISM Trial: Partial Breast Versus Whole Breast Radiation in Ultra-Hypofractionated Irradiation; A Multicenter Study of Toxicity and DosiMetrics
NCT07811635 is registered in ClinicalTrials.gov with Jinnah Postgraduate Medical Centre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PRISM Trial: Partial Breast Versus Whole Breast Radiation in Ultra-Hypofractionated Irradiation; A Multicenter Study of Toxicity and DosiMetrics
- Lead sponsor
- Jinnah Postgraduate Medical Centre
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- September 1, 2026
- Completion date
- December 31, 2027
- Enrollment
- 100 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer early stage breast cancer (stage 1-3)